Clinical Trials Directory

Trials / Completed

CompletedNCT03843216

End Growth Results for Conservative Treatment for Idiopahitc Scoliosis

End-growth Results of Tailored Treatment in 1938 Adolescents With High Risk Idiopathic Scoliosis: a Cohort Study From a Prospective Clinical Database

Status
Completed
Phase
Study type
Observational
Enrollment
1,938 (actual)
Sponsor
Istituto Scientifico Italiano Colonna Vertebrale · Academic / Other
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates in a prospectively collected multicenter cohort the existence, characteristics and determinants of EBPCA, the obtained results and their determinant, the rate of over- and under-treatment and their determinants.

Detailed description

Since an evidence-based personalised conservative approach (EBPCA) to Adolescent Idiopathic Scoliosis has never been checked, the investigators studied a prospectively collected multicenter cohort with the aim to verify in the different clinical situations 1) the existence, characteristics and determinants of EBPCA; 2) the obtained results and their determinant; 3) the rate of over- and under-treatment and their determinants. These results are expected to check the actual evidence in everyday clinic, to provide a benchmark for future studies, and to inform guidelines producers and consequently health policy in high income countries, but also and particularly in low-middle income countries where surgery is difficult due to the high costs, and missing competences and structures.

Conditions

Interventions

TypeNameDescription
OTHERobservationpatients not treated
OTHERPhysiotherapic scoliosis specific exerciseSpecific exercise according to the SEAS (Scientific Exercises Approach to Scoliosis) protocol
DEVICEbracedifferent kind of braces being elastic, rigid or very rigid. All devices are custom made. The hours of application per day varied from 18 to 24h.

Timeline

Start date
2016-01-01
Primary completion
2018-01-01
Completion
2018-07-01
First posted
2019-02-18
Last updated
2019-02-18

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03843216. Inclusion in this directory is not an endorsement.